Rolapitant for the prevention of postoperative nausea and vomiting: A prospective, double-blinded, placebo-controlled randomized trial

Anesthesia and Analgesia

Volumn 112, Issue 4, 2011, Pages 804-812

  Gan, Tong J ^a   Gu, Jiezhun ^b   Singla, Neil ^c   Chung, Frances ^d   Pearman, Michael H ^e   Bergese, Sergio D ^f   Habib, Ashraf S ^a   Candiotti, Keith A ^g   Mo, Yi ^h   Huyck, Susan ^h   Creed, Mary R ^b   Cantillon, Marc ^h  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Lotus Clinical Research Inc   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e Jane Phillips Medical Center   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g UNIVERSITY OF MIAMI   (United States)

^h MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON; PLACEBO; ROLAPITANT;

ABDOMINAL SURGERY; ADULT; ANESTHESIA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EXTUBATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 79953199004     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31820886c3     Document Type: Article

References (15)

1. Gan TJ. Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs 2007;21:813-33 (Pubitemid 47443303)
2. Leslie RA, Shah Y, Thejomayen M, Murphy KM, Robertson HA. The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting. Can J Physiol Pharmacol 1990;68:279-88 (Pubitemid 20107631)
3. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med 1993;329:1790-6 (Pubitemid 23355554)
4. Diemunsch P, Gan TJ, Philip BK, Girao MJ, Eberhart L, Irwin MG, Pueyo J, Chelly JE, Carides AD, Reiss T, Evans JK, Lawson FC, Aprepitant-PONV Protocol 091 International Study group. Single-dose aprepitant vs. ondansetron for the prevention of postoperative nausea and vomiting: a randomized, doubleblind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007;99:202-11 (Pubitemid 47260214)
5. Ling X, Hsu J, Ting N. Partitioning tests in dose-response studies with binary outcomes. In: Ting N, ed. Dose Finding in Drug Development. New York: Springer Verlag, 2006:184-99
6. Tattersall FD, Rycroft W, Francis B, Pearce D, Merchant K, MacLeod AM, Ladduwahetty T, Keown L, Swain C, Baker R, Cascieri M, Ber E, Metzger J, MacIntyre DE, Hill RG, Hargreaves RJ. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 1996;35:1121-9 (Pubitemid 27008187)
7. Amin AH, Crawford TB, Gaddum JH. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol 1954;126:596-618
8. Gonsalves S, Watson J, Ashton C. Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets. Eur J Pharmacol 1996;305:181-5 (Pubitemid 26197605)
9. Tattersall FD, Rycroft W, Hill RG, Hargreaves RJ. Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994. Neuropharmacology 1994;33:259-60
10. Gesztesi Z, Scuderi PE, White PF, Wright W, Wender RH, D'Angelo R, Black LS, Dalby PL, MacLean D. Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology 2000;93:931-7
11. Chung F, Singla N, Singla S, Grenier A, Russo M. Efficacy of the neurokinin-1 receptor antagonist (RA) casopitant for prevention of postoperative vomiting in patients receiving opioids: results of a pooled data analysis. Anesthesiology 2006;105:A206
12. Gan TJ, Apfel CC, Kovac A, Philip BK, Singla N, Minkowitz H, Habib AS, Knighton J, Carides AD, Zhang H, Horgan KJ, Evans JK, Lawson FC. Aprepitant PSG: a randomized, doubleblind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 2007;104:1082-9 (Pubitemid 46649925)
13. Diemunsch P, Schoeffler P, Bryssine B, Cheli-Muller LE, Lees J, McQuade BA, Spraggs CF. Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Br J Anaesth 1999;82:274-6 (Pubitemid 29057630)
14. Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS, Hooper VD, Kovac AL, Kranke P, Myles P, Philip BK, Samsa G, Sessler DI, Temo J, Tramer MR, Vander Kolk C, Watcha M. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007;105:1615-28 (Pubitemid 350190555)
15. Sun R, Klein KW, White PF. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery. Anesth Analg 1997;84:331-6 (Pubitemid 27061398)